全转录组分析揭示了mRNAs和ncRNAs的相互作用,以预测和验证肺转移性骨髓瘤中ceRNA网络的发生
KunPeng Zhu1,2, XingKai Wang1,2, Lin Fan1
1Department of Orthopedics, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Shanghai 200072, PR China.
Journal of Cancer
|September 17, 2025
概括
这项研究揭示了骨髓瘤肺转移中的新型竞争RNA网络. 了解这些相互作用为这种具有挑战性的癌症提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 转移性骨肉瘤 (OS) 的预后不好,治疗选择有限,尤其是肺转移.
- 非编码RNAs (ncRNAs) 和信使RNAs (mRNAs) 在瘤进展中至关重要,但它们在OS肺转移中的调节网络仍然不清楚.
研究的目的:
- 在骨髓瘤肺转移中全面分析lncRNAs,circRNAs,miRNAs和mRNAs的表达特征.
- 识别和描述参与OS肺转移的竞争性内源性RNA (ceRNA) 网络.
- 为潜在的治疗目标验证关键的监管途径.
主要方法:
- 在匹配的原发性和肺转移性OS组织上进行全转录组测序 (RNA-seq).
- 生物信息分析包括基因和基因组的京都百科全书 (KEGG) 和基因本体学 (GO) 途径分析.
- 使用RNA混合和TargetScan识别ceRNA网络,然后对所选途径进行实验验证.
主要成果:
- 在OS肺转移中确定了lncRNAs,circRNAs,miRNAs和mRNAs的明显表达模式.
- 构建了涉及lncRNAs,circRNAs,miRNAs和mRNAs的新型ceRNA网络.
- 通过实验验证了两个特定的ceRNA通路,即 lncRNA PCAT1/miR-370-3p/LRAT 和 circ_0012586/miR-200b-5p/MFAP5.
结论:
- 这项研究阐明了骨髓瘤肺转移中ceRNAs复杂的调节格局.
- 已识别的ceRNA网络和验证的途径为OS肺转移的机制提供了新的见解.
- 这些发现可能会为新的治疗策略铺平道路,以对抗骨髓瘤肺转移.
更多相关视频
相关概念视频
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K


